ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,459.10
1.11%
US Tech 100
18,514.00
1.00%
Dow Jones
40,589.34
1.64%
Brent Oil
79.745
0.00%
Bitcoin
68,114.30
0.46%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Inventiva (IVA) Quote

Inventiva

Inventiva (IVA)

Inventiva SA
2.245
0.035
(1.58%)
Closed July 27 11:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
2.245
Bid
2.23
Ask
2.30
Volume
86,851
2.22 Day's Range 2.46
2.08 52 Week Range 4.55
Market Cap
472.956M
Previous Close
2.21
Open
2.26
Last Trade
2635
@
2.245
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
40,660
Shares Outstanding
210,670,845
Dividend Yield
-
PE Ratio
-4.27
Earnings Per Share (EPS)
-0.52
Revenue
23.16M
Net Profit
-110.43M

About Inventiva

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.inventivapharma.com
Headquarters
Daix, Fra
Founded
1970
Inventiva is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker IVA. The last closing price for Inventiva was 2.21 €. Over the last year, Inventiva shares have traded in a share price range of 2.08 € to 4.55 €.

Inventiva currently has 210,670,845 shares outstanding. The market capitalization of Inventiva is 465.58 € million. Inventiva has a price to earnings ratio (PE ratio) of -4.27.

IVA Latest News

More News

Inventiva secures a new patent in Japan, expanding the IP protection of its lead product candidate lanifibranor

Japanese Patent Office approved Inventiva’s patent application relating to the use of lanifibranor for the treatment of cirrhosis.1This patent strengthens Inventiva’s intellectual property with...

July 25 2024
GlobeNewswire Inc.

Inventiva obtient un nouveau brevet au Japon, élargissant la protection de la propriété intellectuelle de lanifibranor

Inventiva obtient un nouveau brevet au Japon, élargissant la protection de la propriété intellectuelle de lanifibranor ► L'Office des brevets japonais a accordé la demande de brevet d'Inventiva...

July 25 2024
UK Regulatory

Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux

Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux Daix (France), Long Island City (New York, Etats-Unis), le 19 juillet 2024 –  Inventiva (Euronext...

July 19 2024
UK Regulatory

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux Daix (France), Long Island City (New York, United States), July 19, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA...

July 19 2024
UK Regulatory

Inventiva announces a €20.1 million issuance of royalty certificates

Royalty certificates subscribed by Samsara BioCapital and existing shareholders (BVF Partners, NEA, Sofinnova and Yiheng).Royalty of 3% on future net sales of lanifibranor in the United States of...

July 18 2024
GlobeNewswire Inc.

Inventiva annonce l'émission de certificats de royalties pour un montant de 20,1 millions d'euros

Inventiva annonce l'émission de certificats de royalties pour un montant de 20,1 millions d'euros Certificats de royalties souscrits par Samsara BioCapital et des actionnaires existants...

July 18 2024
UK Regulatory

Inventiva fait le point sur son programme clinique NATiV3 évaluant lanifibranor dans la MASH/NASH et sur sa situation financièr

Inventiva fait le point sur son programme clinique NATiV3 évaluant lanifibranor dans la MASH/NASH et sur sa situation financièr Le recrutement dans l'essai clinique de phase III NATiV3 se...

July 05 2024
GlobeNewswire Inc.

Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 2024  

Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 2024   Daix, 21 June 2024  Pursuant to Article 241-2 of the AMF General Regulations...

June 21 2024
GlobeNewswire Inc.

Résultats des votes de l’Assemblée Générale Mixte des actionnaires réunies le 20 juin 2024

Résultats des votes de l’Assemblée Générale Mixte des actionnaires réunies le 20 juin 2024 Daix (France), Long Island City (New York, Etats-Unis), le 21 juin 2024 – Inventiva (Euronext Paris...

June 21 2024
GlobeNewswire Inc.

Combined General Meeting of June 20, 2024 - Availability of the preparatory documents

Daix (France), Long Island City (New York, United States), May 30, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral...

May 30 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.255-10.22.52.562.2291692.345296DE
4-0.655-22.58620689662.92.92.08479172.46193042DE
12-0.775-25.66225165563.023.672.08406602.87748018DE
26-1.255-35.85714285713.54.32.08523263.16809101DE
52-1.16-34.06754772393.4054.552.08552073.46891101DE
156-9.815-81.384742951912.0613.181.88530524.66804222DE
2600.3820.37533512061.86516.31.54658276.93467016DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WINTWindtree Therapeutics Inc
$ 8.24
(150.46%)
48.57M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NBSTWNewbury Street Acquisition Corporation
$ 0.1349
(92.71%)
122.1k
YIBOPlanet Image International Ltd
$ 2.915
(53.43%)
260.07k
CREVCarbon Revolution Public Ltd
$ 9.00
(45.87%)
8.06M
NMHINatures Miracle Holding Inc
$ 0.2035
(-48.06%)
7.69M
TANHTantech Holdings Ltd
$ 0.2585
(-47.23%)
6.75M
DXCMDexCom Inc
$ 64.00
(-40.66%)
53.92M
PSIGPS International Group Ltd
$ 1.42
(-31.40%)
716.26k
POAIPredictive Oncology Inc
$ 1.36
(-27.27%)
6.02M
SLNASelina Hospitality PLC
$ 0.0305
(-18.88%)
408.61M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NVDANVIDIA Corporation
$ 113.06
(0.69%)
293.33M
SQQQProShares UltraPro Short QQQ
$ 9.10
(-2.88%)
176.49M
SGMOSangamo Therapeutics Inc
$ 0.8612
(28.15%)
123.71M

Discussion

View Full Feed
oilin07 oilin07 6 minutes ago
Multiple pennies are coming. If you are not in this you will greatly regret it. Lofe changing.
BLLB
delerious1 delerious1 8 minutes ago
Here we are.....times change and most people adjust, granted the OTC is not what it was but there are still many many opportunities to make money...after all there are over 10,000 stocks trading on the OTC....if that doesn't give you and others an opportunity .....
PEACHMAN PEACHMAN 8 minutes ago
Let me be clear this beautiful Saturday night about IFUS.

The main reason right now that everyone should buy IFUS stock is that they discovered how to break down the lignin in Bagasse and create a new game changing cattle feed product that will change the world called SGP+
IFUS
Codycrusher Codycrusher 9 minutes ago
What’s up y’all, exciting things ahead for PTOP!
PTOP
Konaploinks Konaploinks 9 minutes ago
They’re a bunch of crooks. Any questions?
sentiment_stocks sentiment_stocks 9 minutes ago
It’s your post instead that is misleading.

May 29, 2019
Northwest resolves billing issues with Cognate.

February 20, 2018
https://www.businesswire.com/news/home/20180220006077/en
Cognate is sold to the management team and other investors by LP.
NWBO
oystersnbeer oystersnbeer 10 minutes ago
Kamala and her supporters are smart ,
Donnie and his supporters are stupid,

The contrast is astounding.
nowwhat2 nowwhat2 10 minutes ago
Bitcoin under microscope
Gong Show under microscope

https://investorshub.advfn.com/uimage/uploads/2024/7/27/erpcgbtc_777_27_7d_zoom_645pm_SUMMARY_TRUMP.jpg


NEWS Before, During and After It Happens

https://investorshub.advfn.com/uimage/upl
BTCUSD
janice shell janice shell 11 minutes ago
No, it did not. It had everything to do with the SEC. First, in 2013 it took down the enormously popular Awesome Penny Stocks promotional group. In the past, new promoters popped up to replacer the ones the enforcement agencies very occasionally went after. But this time, the SEC methodically pursue
delerious1 delerious1 11 minutes ago
It's a shame so many left iHub lately....and so avoidable
chipboarder chipboarder 12 minutes ago
So we are about 2 weeks from the Q2 Earnings Report and it’s fun to speculate…we know that the rental income will be about $133k (from the Qi-10Q) and we know that we have slightly more than $22 million in interest bearing investments (assuming an annual rate of only 4% or 1% per quarter we can expe
LQMT
PEACHMAN PEACHMAN 12 minutes ago
IFUS future is a grant,new sales revenues and awareness.

Legislation also wanted a written report before Feb1 on Research Validation and Commerilazation of bagasse .

IFUS will continue to generate revenues from cattle,mulch,oil absorption and Intact Nutrition products.
IFUS
Lightning_Rod Lightning_Rod 12 minutes ago
This is an endorsement of Polariton and most likely and secondly Lightwave.

L_R
LWLG
jeffree jeffree 13 minutes ago
The 3-month chart for GME and the other one...in comparison...note; I mentioned this a couple weeks ago...

GME- eyJsYXlvdXQiOnsiaW50ZXJ2YWwiOiJkYXkiLCJwZXJpb2RpY2l0eSI6MSwidGltZVVuaXQiOm51bGwsImNhbmRsZVdpZHRoIjoxNC44NTQ4Mzg3MDk2Nzc0MiwiZmxpcHBlZCI6ZmFsc2UsInZvbHVtZVVuZGVybGF5Ijp0cnVlL
GME LUMN
Welcome2Pinkyland Welcome2Pinkyland 13 minutes ago
I’ll see your .001 and buy as low as .0001. As far $100+ stocks mainly only options.
Hi_Lo Hi_Lo 14 minutes ago
Yep, Jake threw a bunch of money in this just to lose. lol

Funny how you say that here while at the same time say this about Jake P. Noch (who is attempting a custodianship here with BCAP and is also CEO for the TA gagged ticker SONG) on his other (SONG) stock board...

BCAP
PEACHMAN PEACHMAN 15 minutes ago
IFUS has always been a legitimate company that educates everyone with Letters to Shareholders ,Tweets,and occasional videos on TV and with podcasts.

IFUS also works with the legislators in the Senate and the House to promote bills that help the company,sugar mills,cattle ranchers and
IFUS
Hercules1 Hercules1 16 minutes ago
it is game on now.

everybody that is here is buying on monday:

all the flippers will be forced to chase.

smart traders will add more to their stash.

shorts will be forced to cover.

this stock is opening near .004 on monday.
HIRU
BestFishes BestFishes 16 minutes ago
time for a re-rating?
PLNH
rollingsandman rollingsandman 17 minutes ago
post mortem
PHBI
fuagf fuagf 17 minutes ago
OMOLIVES, Why aren't i surprised your vote won't be consistent with the sentiments on tax you
have posted here. On those words no way you could vote for Trump. Kennedy wouldn't do...
LOB LOB 17 minutes ago
5 Months but whose counting.. lol
NSAV
Rubyred77 Rubyred77 18 minutes ago
Why not expect nothing and be suprised if it ends up tomorrow is the day. Everyone, long and short, is guessing when that day is and planning accordingly.

AVXL
Not likely Not likely 18 minutes ago
Everything announced by Park has been done with purpose.

To deceive.

Preposterous announcements and lying timelines.

No proof of anything.


And the weak are holding while the s/p slowly crumbles.
SPZI
jeffree jeffree 18 minutes ago
..."Baby did a bad bad thing....baby did a bad bad thing"...😬...Look and see...


https://finance.yahoo.com/quote/LUMN/chart/#eyJsYXlvdXQiOnsiaW50ZXJ2YWwiOiJkYXkiLCJwZXJpb2RpY2l0eSI6MSwidGltZVVuaXQiOm51bGwsImNhbmRsZVdpZHRoIjoxNC44NTQ4Mzg3MDk2Nzc0MiwiZmxpcHBlZCI6ZmFsc2UsI
LUMN

Your Recent History

EU
IVA
Inventiva
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved